Genvira specializes in viral engineering. We design, construct and characterize customized DNA and RNA viruses for:
- Cancer immunotherapy
- Gene therapy
In addition, Genvira conducts viral and non-viral based cell engineering.
Our contract research services include
- End-to-end engineering
- Consulting for CMC and regulatory filing
- Pre-clinical animal models and efficacy study
- Assay development
- In vitro MOA
- In vivo efficacy study
Our small scale production suite can manufacture sufficient materials for pre-clinical studies.
We’re proud to use our world-leading proprietary engineering technologies to quickly deliver high-quality engineered vectors and cells.